Navigation Links
Nine Year Ban Fails to Eradicate Asbestos Related Diseases
Date:11/27/2008

Nine years after its use was banned, statistics show that nearly 4,000 people in the UK die each year from the effects of asbestos exposure whilst at work.

Manchester,UK (PRWEB) November 27, 2008 -- On 24th November 1999, the Government's ban on the use of Asbestos came into force. Nine years on, statistics show that nearly 4,000 people in the UK die each year from the effects of asbestos exposure whilst at work. This figure, as predicted in 1999, exceeds the number of people killed in Road Traffic Accidents and the figure is set to rise. Yet despite these shocking figures, tradesmen and women continue to become exposed and fail to recognise that dangers still exist. The dangers of exposure are still so great that the Health & Safety Executive are currently running a campaign highlighting their concerns.

Although white, blue and brown asbestos have all been banned in the UK, the material remains in the fabric of some 500,000 buildings in the UK. But many workers seem to believe that the ban means no future exposure is likely. This couldn't be further from the truth. Exposure is still possible if cutting or drilling disturbs the asbestos fibres during any refurbishment of a building built before 2000. If asbestos is damaged whilst being worked with, the fine fibres become airborne and can be inhaled. Whilst protective clothing such as face masks is available, it is not always used. Partners of workers can even be exposed to asbestos from coming into contact with their clothing. Those most at risk work or have worked in the following trades: plumbing; building and bricklaying; roofing; ship building; flooring and carpentry and joinery. There's no known safe level of asbestos exposure. Put simply, the higher the levels of asbestos and the longer the time someone is exposed to it, the greater their risk of developing problems. Only now are we experiencing the after effects of e
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Federal research plan to determine nanotech risks fails to deliver
2. States HMO Report Card Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability
3. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
4. Experimental Drug Fails Against Heart Failure
5. NSAID Drug Therapy Fails to Ease Back Pain
6. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
7. Steroid Fails to Ease Meningitis in Trials
8. Pharmaceutical market fails pregnant women; and more
9. Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today
10. Post-Op Chemo Fails to Boost Survival in Stomach Cancers
11. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nine Year Ban Fails to Eradicate Asbestos Related Diseases
Nine Year Ban Fails to Eradicate Asbestos Related Diseases
Other Medicine News:Health News:Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 2Health News:Halloween Events in Sacramento Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 3Health News:Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel 2Health News:Healthy planet, places and people at risk 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 3Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 4Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 5Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 6Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 7Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 8Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 9Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 10
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2Americans United for Lifes Statement on Finance Committee Vote 59407 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 2New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 3